Salai, G., Zelenika, M., Hrkač, S., Trkulja, V., Bilandžić, J., Grgurević, I. ... Grgurević, L. (2021). Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis. Croatian Medical Journal, 62. (3), 264-269. doi: 10.3325/cmj.2021.62.264
Salai, Grgur, et al. "Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis." Croatian Medical Journal, vol. 62, no. 3, 2021, pp. 264-269. https://doi.org/10.3325/cmj.2021.62.264
Salai, Grgur, Marko Zelenika, Stela Hrkač, Vladimir Trkulja, Joško Bilandžić, Ivica Grgurević, Ruđer Novak and Lovorka Grgurević. "Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis." Croatian Medical Journal 62, no. 3 (2021): 264-269. https://doi.org/10.3325/cmj.2021.62.264
Salai, G., et al. (2021) 'Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis', Croatian Medical Journal, 62(3), pp. 264-269. doi: 10.3325/cmj.2021.62.264
Salai G, Zelenika M, Hrkač S, Trkulja V, Bilandžić J, Grgurević I, and sur.. Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis. Croatian Medical Journal [Internet]. 2021 June 30 [cited 2024 December 01];62(3):264-269. doi: 10.3325/cmj.2021.62.264
G. Salai, et al., "Plasma levels of soluble TGF β receptor type III: no apparent promise as a marker in acute pancreatitis", Croatian Medical Journal, vol. 62, no. 3, pp. 264-269, June 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:377435. [Accessed: 01 December 2024]